Aphthasol, Amlexanox Newswire

Aphthasol, Amlexanox Newswire

Comprehensive Real-Time News Feed for Aphthasol, Amlexanox (generic).

Results 1 - 8 of 8 in Aphthasol, Amlexanox (generic)

  1. Global Antianaphylaxis Drugs Market 2017 Consumption Research Report...Read the original story w/Photo

    Oct 4, 2017 | SBWire

    Global Antianaphylaxis drugs Market 2017-2022 Forecast Industry Statistics, Valuable Source of Guidance, Direction for Companies and Individuals Interest in the Market Share. A Research Legwork on " Global Antianaphylaxis drugs Market 2017-2022 " represent the market share and size of Antianaphylaxis drugs in international Industry.

    Comment?

  2. Repurposed asthma drug shows blood sugar improvement among some diabeticsRead the original story w/Photo

    Jul 7, 2017 | Medical News Today

    After 12 weeks of taking an anti-asthma drug, a subset of patients with type 2 diabetes showed a clinically significant reduction in blood glucose during a randomized, double blind, placebo-controlled clinical trial, report University of California San Diego School of Medicine and University of Michigan researchers.

    Comment?

  3. Asthma drug shows promise in treating obesity and diabetesRead the original story w/Photo

    Jul 6, 2017 | WebWire

    Michigan Medicine endocrinologist Elif Oral, M.D., leads clinical trial of asthma drug that shows promise as an obesity and diabetes medication. After 12 weeks of taking an anti-inflammatory asthma drug, obese patients with type 2 diabetes showed a clinically significant drop in blood glucose.

    Comment?

  4. Asthma Drug Proven to Help DiabetesRead the original story w/Photo

    Jul 5, 2017 | KIMO

    Researchers have found that Amlexanox, a drug used to treat asthma, is actually helping lower blood glucose levels. The inhibitor caused both mice and humans to lose weight and increase insulin sensitivity, improving their diabetes.

    Comment?

  5. Anti-asthma drug shows blood glucose improvement among some patients with type 2 diabetesRead the original story w/Photo

    Jul 5, 2017 | Medical News

    After 12 weeks of taking an anti-asthma drug, a subset of patients with type 2 diabetes showed a clinically significant reduction in blood glucose during a randomized, double blind, placebo-controlled clinical trial, report University of California San Diego School of Medicine and University of Michigan researchers.

    Comment?

  6. Asthma drug shows potential benefit for type 2 diabeticsRead the original story w/Photo

    Jul 5, 2017 | The San Diego Union-Tribune

    Alan Saltiel is director of the Institute for Diabetes and Metabolic Health at UC San Diego School of Medicine. The drug, amlexanox, reduced blood sugar levels and liver fat in one-third of patients in the placebo-controlled study.

    Comment?

  7. Repurposed asthma drug shows blood sugar improvement among some diabeticsRead the original story w/Photo

    Jul 5, 2017 | PhysOrg Weblog

    After 12 weeks of taking an anti-asthma drug, a subset of patients with type 2 diabetes showed a clinically significant reduction in blood glucose during a randomized, double blind, placebo-controlled clinical trial, report University of California San Diego School of Medicine and University of Michigan researchers.

    Comment?

  8. Canker Sores: Causes & TreatmentsRead the original story w/Photo

    Jun 13, 2017 | Live Science

    Canker sores, or aphthous ulcers, are small sores on the inside of the mouth. They can occur in both men and women of any age, but they're more common in women and in people between the ages of 10 and 40. Around 20 percent of the population get these types of sores, according to the National Institutes of Health .

    Comment?